跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUVPOSA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CUVPOSA
Authorized
STANDARD
CUVPOSA
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9cec42f038a0db48
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
9cec42f038a0db48
Drug Approval Canada Name
CUVPOSA
Product Name
CUVPOSA
Status
Marketed
Status Date
2022-11-01
Original Market Date
2018-04-03
Din
02469332
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:08.08
Atc Original
A03AB02 GLYCOPYRRONIUM
Atc Name
a 03 ab 02
Aig Number
0102396002
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
GLYCOPYRROLATE
1 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9cec42f038a0db48
Type
Standard
Back to Health Canada Approvals